GYRE
Gyre Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Gyre Therapeutics (GYRE) Stock: Buy, Sell, or Hold?
$4.26
+0.03 (+0.71%)
▲
5d:
-4.05%
30d:
-36.51%
90d:
-34.86%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (95%)
Quality Score
55/100
Position
OVERSOLD
30-Day Fair Range
$4.81 – $6.90
Position: OVERSOLD
Forward P/E & Valuation
-17.4x
CHEAP
vs 45.4x historical avg
Wall Street Target
$18.67
+338.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$3.97 / $6.99
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: GYRE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Get Alerted When GYRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: GYRE is currently trading at $4.26, which is considered oversold relative to its 30-day fair value range of $4.81 to $6.90. From a valuation perspective, the stock is trading at a discount (Forward PE: -17.4) compared to its historical average (45.4). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, GYRE is in a downtrend. Immediate support is located at $3.97, while resistance sits at $6.99.
Market Sentiment: GYRE scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.67 (+338.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GYRE is in a downtrend. Immediate support is located at $3.97, while resistance sits at $6.99.
Market Sentiment: GYRE scores 70/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.67 (+338.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.81 -
$6.90
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
95.2%
Trading Range & Key Levels
30-Day Trading Range
$4.81 -
$6.90
Current vs Trading Range
OVERSOLD
Support Level
$3.97
Resistance Level
$6.99
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (70/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 338.2% below Wall St target ($18.67)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- CAUTION: Bottoming setup, but lagging the sector by 24% over 20 days — wait for relative strength
Fundamental Context
Forward P/E (Next Year Est.)
-17.39
Wall Street Target
$18.67
(+338.2%)
Revenue Growth (YoY)
0.7%
Earnings Growth (YoY)
166.2%
Profit Margin
-22.7%
PE vs Historical
-17.4 vs 45.4
CHEAP
Share GYRE Analysis
Share this live GYRE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (GYRE)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 7, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish trader on StockTwits expressed excitement about a potential 'mega find' for $GYRE, but no recent news articles were available to provide additional context.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 8:56 AM ET
Data refreshes hourly during market hours. Next update: 9:56 AM
Data refreshes hourly during market hours. Next update: 9:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GYRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 51 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
16 analysts |
$107 | 50 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive GYRE Research Pages
